Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
0 investors
A28 Therapeutics develops a targeted oncolytic peptide platform for treating multiple cancer types, with its lead candidate AT-101 in late-stage development for metastatic ovarian cancer with liver metastases and hepatocellular carcinoma. The company is also exploring combinations of AT-101 with immuno-oncology drugs and chemotherapy.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Abfero Pharmaceuticals is a clinical-stage pharmaceutical company developing oral iron chelators that target iron as a therapeutic pathway for diseases of iron overload. Its lead brain-penetrant small molecule, SP-420, is aimed at conditions such as transfusional systemic iron overload and age-related macular degeneration.
0 investors
0 investors
0 investors
0 investors
0 investors
ABLi Therapeutics develops small molecule inhibitors targeting Abelson tyrosine kinases (c-Abl) to treat Parkinson's disease, Parkinson's-related neurodegenerative diseases, and other neurological conditions linked to Abl kinase dysfunction. Its RAMP drug innovation engine designs Abl kinase inhibitors, including its lead candidate risvodetinib, aimed at improved brain penetration, potency, and safety.
0 investors
0 investors
Absco Therapeutics develops a drug delivery platform based on thermogelling polymers that shift from liquid to solid at body temperature to form controlled-release depots for sustained, on-target therapy. Its lead candidate ABS005 is a non-surgical intralesional treatment for high-grade cervical intraepithelial neoplasia (CIN2/3), with the platform targeting cancers and precancers.
0 investors
0 investors
0 investors
0 investors
ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation. The company serves hospitals and medical device manufacturers seeking to reduce catheter-related bloodstream infections and sepsis.
0 investors
0 investors
0 investors
0 investors
Access Bio develops in vitro diagnostics technology, producing rapid diagnostic tests, molecular tests, analyzers, and COVID-19 tests (including PCR, serology, and antigen testing) to detect malaria and other diseases. It serves international public health agencies and organizations.
0 investors